
Jason Hannon
THE COLLAPSE in the share price of Mainstay Medical earlier this month has seen million wiped off the company’s market capitalisation. However, the market overreaction could present opportunities for intrepid investors who are happy to take a long-term punt on the potentially lucrative medical device being developed by this Irish company. While the outcome of… Read more »
This content is only available to Phoenix subscribers.




